Skip to main content

ZANDELISIB

Chemical FDA Substance Registry (openFDA)
Chemical Identification
CAS Number1401436-95-0
INCI Name4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine
PubChem CID 66571003
Molecular FormulaC31H38F2N8O
InChIKeyInChI=1S/C31H38F2N8O/c1-31(
SMILESCC(C)(CC1=CC=CC=C1C2CCN(CC2)C)NC3=NC(=NC(=N3)N4CCOCC4)N5C6=CC=CC=C6N=C5C(F)F
Known Aliases (11)
Common Name
ACC-524 ME-401 PW-143 PWT-143 PWT143 zandelisib [INN] ZANDELISIB [JAN] ZANDELISIB [USAN] Zandelisib [WHO-DD]
Scientific Name
1,3,5-TRIAZIN-2-AMINE, 4-(2-(DIFLUOROMETHYL)-1H-BENZIMIDAZOL-1-YL)-N-(1,1-DIMETHYL-2-(2-(1-METHYL-4-PIPERIDINYL)PHENYL)ETHYL)-6-(4-MORPHOLINYL)- 4-(2-(DIFLUOROMETHYL)BENZIMIDAZOL-1-YL)-N-(1,1-DIMETHYL-2-(2-(1-METHYL-4-PIPERIDYL)PHENYL)ETHYL)-6-MORPHOLINO-1,3,5-TRIAZIN-2-AMINE
Data Sources (1)
Source Source ID Name in Source Properties
FDA Substance Registry (openFDA) 8Z28M5SX0X ZANDELISIB CAS: 1401436-95-0
INN: 11202
USAN: JK-06
ChEMBL: CHEMBL3545112
SMS_ID: 300000023641
PUBCHEM: 66571003
FDA UNII: 8Z28M5SX0X
NCI_THESAURUS: C123925
FDA ORPHAN DRUG: 849021
Record Info
IDM44kfFYZ5SxV6x7AF5dm5A
CreatedApril 10, 2026, 7:49 p.m.
ModifiedApril 11, 2026, 12:17 a.m.
EnrichedApril 11, 2026, 12:09 a.m.
Data SourceFDA Substance Registry (openFDA)